176 EUR
7
4.14%
Last update Dec 5, 9:26 PM CET
Market closed
Day range
176
176
Previous close
169
Open
176
Access this stock data via API
Subscribe
Ascendis Pharma A/S
176.00
7
4.14%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 213.6M 158.0M 101.0M 173.9M
Cost of revenue 22.4M 31.4M 17.5M 14.0M
Gross profit 191.3M 126.6M 83.4M 159.9M
Operating expense
Research & development 66.9M 72.0M 86.6M 79.3M
Selling general and admin 111.7M 105.7M 95.6M 78.8M
Other operating expenses
Operating income 11.0M -53.0M -100.8M 383K
Non operating interest income
Income 3.3M 55.1M 28.9M -14.9M
Expense 19.7M 33.0M 44.8M -5.0M
Other income expense -52.0M -4.1M 23.1M -39.1M
Pretax income -57.4M -35.0M -93.6M -37.4M
Tax provision 3.6M 3.8M 1.1M 1.1M
Net income -61.0M -38.9M -94.6M -38.5M
Basic EPS -1 -0.6 -1.6 -0.6
Diluted EPS -1 -0.8 -1.6 -0.6
Basic average shares 60.8M 60.5M 60.0M 59.8M
Diluted average shares 60.8M 63.9M 60.0M 59.8M
EBITDA 10.8M 2.3M -40.8M -37.9M
Net income from continuing op. -61.0M -38.9M -94.6M -38.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 3 hours 15 minutes

04:44
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).